Hypervirulent *Klebsiella pneumoniae* (hvKP) strains can cause invasive liver abscess syndrome, which is characterised by liver abscess with extrahepatic complications including central nervous system involvement, necrotising fasciitis or endophthalmitis ([@B7]). hvKP was first reported in Taiwan in 1985 and, since then, infections caused by hvKP have been described in several parts of the world, with many cases reported in Southeast Asia ([@B5]). In the Americas, invasive liver abscess syndrome has been reported in the United States of America, Canada and Argentina ([@B7]). However, this strain has not been previously reported in Brazil. Recently, a 57-year-old woman with diabetes mellitus was admitted to the emergency department with a history of fever, nausea, vomiting and mental confusion for five days. On the day of admission, she was comatose, icteric and had a poor general appearance. Her temperature was 37.8°C and her blood pressure, pulse and respiratory rate were 110/60 mmHg, 96 beats/min and 48 breaths/min, respectively. Respiratory and cardiovascular auscultations were normal; however, a neurological examination revealed neck rigidity. Bacterial meningitis was suspected and ceftriaxone 2 g IV q12 h was empirically prescribed after performing a diagnostic lumbar puncture. Her cerebrospinal fluid (CSF) was xanthochromic and showed glucose 0.0 mg/dL, protein 485 mg/dL and 8,640 cells/mm^3^ (8,121 neutrophils/mm^3^ and 259 lymphocytes/mm^3^). Direct examination of her CSF revealed Gram-negative bacilli. At admission, she also had the following altered laboratory tests: glycaemia (264 mg/dL), serum creatinine (2.95 mg/dL), blood urea nitrogen (152 mg/dL), alkaline phosphatase (177 mg/dL), gamma-glutamyl transferase (138 mg/dL), alanine transaminase (50 mg/dL), aspartate transaminase (36 mg/dL), total bilirubin (0.59 mg/dL), indirect bilirubin (0.18 mg/dL), direct bilirubin (0.41 mg/dL) and international normalised ratio (1.19). Brain and multiple liver abscesses (segments IV, V and VIII) were detected through brain and abdominal computed tomography scans. *K. pneumoniae* grew on blood (A58300) and CSF (A58301) cultures and both isolates were susceptible to all antimicrobials tested using a BDPhoenix Automated System. The isolates were then submitted to the Alerta Laboratory, Federal University of São Paulo for further characterisation. After surgical drainage of the brain abscess and percutaneous drainage of the liver abscess, the patient's clinical condition deteriorated; ceftriaxone was replaced by meropenem 2 g IV q8 h four days later. Eight days after admission, the patient developed ventilator-associated pneumonia and *K. pneumoniae* (also susceptible to all antibiotics tested) and multidrug-resistant *Acinetobacter baumannii* were isolated from semiquantitative tracheal aspirate cultures. Polymyxin B 1.125.000 UI IV q12 h was added to the meropenem. Fifteen days later, multidrug-resistant *A. baumannii* bacteraemia was detected despite the use of broad antimicrobial therapy; thus, ampicillin-sulbactam 3 g IV q6 h was added to the antimicrobial regimen. At 45 days after admission, the patient died due to septic shock and *A. baumannii* was again recovered from blood culture. The patient had no previous history of cholelithiasis, liver cirrhosis, malignancies or steroid or chemotherapy use. In addition, the patient had no history of international travel or known contact with Asian individuals.

At Alerta Laboratory, the identification and antimicrobial susceptibility profile of the *K. pneumoniae* strains were confirmed by MALDI-TOF and the agar dilution method. The minimum inhibitory concentration (MIC) results were typically interpreted according to the [@B2]; however, The European Committee on Antimicrobial Susceptibility Testing (Breakpoint tables for interpretation of MICs and zone diameters, v.4.0) were used for determining the MIC of polymyxin B. Both isolates showed susceptibility to all antimicrobials tested: amoxicillin-clavulanate (MIC ≤ 4/2 µg/mL), ceftazidime (MIC ≤ 0.25 µg/mL), cefepime (MIC ≤ 0.25 µg/mL), meropenem (MIC ≤ 0.06 µg/mL), imipenem (MIC ≤ 0.06 µg/mL), ertapenem (MIC ≤ 0.06 µg/mL), ciprofloxacin (MIC ≤ 0.06 µg/mL), amikacin (MIC 2 µg/mL), tigecycline (MIC 0.25 µg/mL), fosfomycin (MIC 16 µg/mL), piperacillin/tazobactam (MIC 4 µg/mL) and polymyxin B (MIC ≤ 0.125 µg/mL). The genetic similarity of the strains was evaluated by pulsed field gel electrophoresis (PFGE) and multilocus sequence typing techniques, as previously described ([@B8], [@B3]). Both strains exhibited identical PFGE patterns and were found to belong to ST23 ([@B8]). Genomic DNA was extracted from both isolates (QIAamp DNA Mini Kit, Qiagen^®^) and virulence-encoding genes were detected by polymerase chain reaction (PCR) followed by DNA sequencing ([Table](#t01){ref-type="table"}). Both strains presented a hypermucoviscosity phenotype and possessed *magA*, *rmpA*, *kfu* and aerobactin genes. *MagA* is a mucoviscosity-associated gene that is related to the extensive production of a polysaccharide capsule and increased resistance to phagocytes. The *rmpA* gene increases capsular polysaccharide biosynthesis and mucoviscosity. The *kfu* gene encodes an iron-uptake system that is associated with a hypermucoviscosity phenotype and increased virulence ([@B6], [@B4]).

TABLEFactors evaluatedTarget geneSequence (5'-3')Annealing temperature (°C)Amplicom (pb)ReferencesMucoviscosity-associated gene A*maga-F*CCGATGGTTGGGTTAGCTTT60801This paper*maga-R*CTGGCCATATTGCTCCGTTGRegulator of mucoid phenotype*rmpa-F*AGTTAACTGGACTACCTCTGTTTC60543This paper*rmpa-R*TACTTGGCATGAGCCATCTTTIron acquisition system*kfu-F*ATAGTAGGCGAGCACCGAGA60520[@B9]*kfu-R*AGAACCTTCCTCGCTGAACAAerobactin*Aero_1-F*GCATAGGCGGATACGAACAT60556[@B9]*Aero_1-R*CACAGGGCAATTGCTTACCTAerobactin*Aero_2-F*CTGTCGGCATCGGTTTTATT60531[@B9]*Aero_2-R*TGGCGTGTCGATTATTACCAThermotolerance phenotype*clpk-F*GTTGTGCGACGACCATTACC60557This paper*clpk-R*TCAGGAAATGCTCTGGACCGsequence of primers used for amplification of virulence encoding genes

As described in this case report, the patient had the classical clinical and microbiological characteristics of community-acquired hvKP: liver abscess with metastatic infections (bacteraemia and meningitis) caused by *K. pneumoniae* displaying a hypermucoviscosity phenotype and belonging to capsular serotypes K1 and ST23, with the presence of the *magA* and *rmpA* genes ([@B1], [@B7]). In addition, the patient was diabetic, a risk factor reported by [@B7]. This clinical case report is important for increasing awareness among Brazilian clinicians with regard to the fact that hvKP ST23 is already circulating in our region and causing serious infections in patients without any previous history of international travel to Asia.

[^1]: RLC and MFV contributed equally to this work.
